LEADER 01770nas  2200565-  450 
001 996321390303316
005 20240321155614.0
011   $a2475-0581
035   $a(DE-599)ZDB2964147-0
035   $a(OCoLC)963937864
035   $a(CKB)3710000001157540
035   $a(CONSER)--2016209645
035   $a(EXLCZ)993710000001157540
100   $a20161122a20179999  o--         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPsychiatry and clinical psychopharmacology
210  1$aAbingdon, UK :$cTaylor & Francis,$d[2017]-
210 31$aIstanbul, Turkey :$cTurkish Association for Psychopharmacology
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a2475-0573 
531 0 $aPsychiatry clin. psychopharmacol.
606   $aPsychopharmacology$vPeriodicals
606   $aPsychiatry$vPeriodicals
606   $aPsychotropic Drugs$xtherapeutic use
606   $aMental Disorders$xdrug therapy
606   $aPsychopharmacology
606   $aPsychiatry
606   $aPsychiatry$2fast$3(OCoLC)fst01081152
606   $aPsychopharmacology$2fast$3(OCoLC)fst01081659
608   $aPeriodical.
608   $aPeriodicals.$2fast
610   $aPharmacy, Therapeutics, & Pharmacology
615  0$aPsychopharmacology
615  0$aPsychiatry
615 12$aPsychotropic Drugs$xtherapeutic use.
615 22$aMental Disorders$xdrug therapy
615  2$aPsychopharmacology.
615  2$aPsychiatry.
615  7$aPsychiatry.
615  7$aPsychopharmacology.
676   $a616
906   $aJOURNAL
912   $a996321390303316
996   $aPsychiatry and clinical psychopharmacology$92203929
997   $aUNISA